Pneumococcal conjugate second or third-dose vaccines (PCVc) in Switzerland
Switzerland: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 92.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Switzerland, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Switzerland is 92.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 1.1% on the previous year and up 15.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Switzerland peaked at 92.0% in 2025 and was at its lowest, 13.0%, in 2008.
Switzerland ranks 56th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 13.0% | — |
| 2009 | 25.0% | +92.3% |
| 2010 | 37.0% | +48.0% |
| 2011 | 50.0% | +35.1% |
| 2012 | 62.0% | +24.0% |
| 2013 | 75.0% | +21.0% |
| 2014 | 80.0% | +6.7% |
| 2015 | 80.0% | +0.0% |
| 2016 | 80.0% | +0.0% |
| 2017 | 84.0% | +5.0% |
| 2018 | 84.0% | +0.0% |
| 2019 | 84.0% | +0.0% |
| 2020 | 86.0% | +2.4% |
| 2021 | 88.0% | +2.3% |
| 2022 | 89.0% | +1.1% |
| 2023 | 89.0% | +0.0% |
| 2024 | 91.0% | +2.2% |
| 2025 | 92.0% | +1.1% |
Switzerland compared with similar countries
- Switzerland's 92.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (63 countries reporting)
- Switzerland's 92.0% is above the median for Europe & Central Asia, which is 87.0%, 1.1× the median. (51 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Switzerland changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +92.3% | 13.0% | 25.0% |
| 2010 | +48.0% | 25.0% | 37.0% |
| 2011 | +35.1% | 37.0% | 50.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.0% | 13.0% | 25.0% | 2 |
| 2010s | 71.6% | 37.0% | 84.0% | 10 |
| 2020s | 89.2% | 86.0% | 92.0% | 6 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,104 deaths per 1,000 people (2090)
- Number of infants who die before age 1 46 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2023)
- Population ages 00-04, female, annual growth rate 0.0481 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0233 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0927 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Switzerland?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Switzerland was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Switzerland?
- The highest recorded value was 92.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Switzerland?
- The lowest recorded value was 13.0% in 2008.
- How does Switzerland rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Switzerland ranks 56th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Switzerland?
- Over the last ten years it is up 15.0%. The long-run trend across the full record is rising.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).